In the past few months, there has been an increase in cases of the Delta variant of SARS-CoV-2 in countries around the world, and has become a dominant variant in many countries. As per the Centers for Disease Control and Prevention (CDC). Delta variant is more infectious than preexisting ones.
Head of the Oxford Vaccine GroupProf. Sir Andrew Pollard who contributed to the development of the Oxford-AstraZeneca vaccine, has said that ....
Tags : Delta variant, Oxford-AstraZeneca vaccine, SARS-CoV-2, Sir Andrew Pollard, Oxford Vaccine Group, ,
comments (0)